Profil
Yang Sheng Lin is currently General Manager, Director & Chief Researcher at Tripartite Therapeutics, Inc. since 2015.
Formerly, Dr. Lin was Chief Scientific Officer at Medigen Biotechnology Corp.
from 2012 to 2014.
Education includes a doctorate from Harvard University.
Aktiva positioner av Yang Sheng Lin
| Företag | Position | Start |
|---|---|---|
| TRIPARTITE THERAPEUTICS INC. | Direktör/Styrelseledamot | 2015-08-01 |
Tidigare kända positioner av Yang Sheng Lin
| Företag | Position | Slut |
|---|---|---|
| MEDIGEN BIOTECHNOLOGY CORP. | Teknisk/Vetenskaplig/F&U Direktör | - |
Yang Sheng Lins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 3 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medigen Biotechnology Corp.
Medigen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Hanyang Biotechnology Ltd.
Hanyang Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs and antibody-drug conjugate therapies for cancer | Health Technology |
















